ZFIN Image: Hou et al., 2022, Figure 11

Image

Figure Caption

Figure 11

WNK1?OSR1 axis inhibitors combined with oligo-fucoidan attenuate HCC proliferation. (a) The treatment scheme of WNK1 and OSR1 inhibitors combined with oligo-fucoidan in [HBx,src,p53^?/?,RPIA] HCC transgenic fish. The expression of proliferation markers (b) ccne1, (c) cdk1, and (d) cdk2 in various combinations of drug-treated 5-month-old [HBx,src,p53^?/?,RPIA] (HSPR) transgenic fish compared to WT. Rego: Regorafenib, Rafox: Rafoxanide as OSR1 inhibitor; WNK463 as WNK1 inhibitor; OF: oligo-fucoidan. The quantification of the histopathological features derives from H&E stain: (e) mitotic figures, (f) trinucleated hepatocytes, (g) karyomegalic cells in various combinations of drug-treated 5-month-old [HBx,src,p53^?/?,RPIA] transgenic fish compared to WT. (h) The expression of cell senescence marker il1? in various combinations of drug-treated 5-month-old [HBx,src,p53^?/?,RPIA] (HSPR) transgenic fish compared to WT. We performed three replicates, and for each qPCR, there are triplicates for each sample. Five adult fish are included in each experiment. One-way ANOVA analysis followed by multiple analysis of variance was used to identify the statistical significance between groups. *: p ? 0.05; **: p ? 0.01; ***: p ? 0.001; ****: p ? 0.0001; ns: no-significance.

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int. J. Mol. Sci.